We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.00
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 23.00
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Mine Sale

25 Feb 2008 14:30

Thistle Mining Inc.25 February 2008 Completion of Sale of President Steyn Gold Mine Toronto, February 25, 2008: Thistle Mining Inc. ("Thistle" or the "Company")(AIM: TMG) announced today that the sale of Thistle's direct and indirectinterests in President Steyn Gold Mines (Free State) (Pty) Ltd to Pamodzi GoldLimited ("Pamodzi") (JSE:PZG) under the terms of a Sale of Shares and ClaimsAgreement dated October 29, 2007, as amended ("SSCA") and previously announcedby the Company, has been completed. The consideration payable by Pamodzi after adjustments is ZAR232.8 million(approximately US$ 29.8 million at an exchange rate of ZAR 7.80 to the US$) (the"Purchase Consideration"). The Purchase Consideration will be satisfied throughthe payment of (i) ZAR 3.5 million in cash; (ii) ZAR92.9 million in the form of9,767,558 Pamodzi shares issued at a ZAR9.51 per share (a 10% discount to thevolume weighted average traded price over the 30 trading days prior to February21, 2008); and (iii) ZAR 136.4 million as a loan receivable ("Loan") from ClidetNo 776 (Pty) Ltd ("Clidet"), a wholly owned subsidiary of Pamodzi ResourcesLimited, and a "B" ordinary share of Clidet. Under the terms of the Subscription Agreement dated October 29, 2007, asamended, between Pamodzi Resources Limited and Clidet, Clidet will acquire9,259,927 ordinary shares in Pamodzi ("Underlying Pamodzi Gold Shares") for anaggregate amount of ZAR 136.4 million at a subscription price of ZAR14.729 pershare. The Pamodzi share price closed at ZAR10.40 per share on 22 February 2008.In terms of the Loan and Subscription Agreement dated February 04, 2008, asamended, between Thistle, Pamodzi Resources Limited and Clidet (the "Loan andSubscription Agreement"), on or after May 31, 2009 (or in limited circumstances,prior thereto), Thistle will be entitled to repayment of the Loan includinginterest calculated at 12% per annum ("Loan Settlement Amount"); provided,however, that in circumstances where the Loan Settlement Amount is greater thanthe value of the Underlying Pamodzi Gold Shares, Thistle's entitlement to suchrepayment will be limited to the value of (or proceeds of) the UnderlyingPamodzi Gold Shares. Thistle is entitled, as the holder of a "B" ordinary shareof Clidet, to a distribution of 80% of the amount by which the value (orproceeds) of the Underlying Pamodzi Gold Shares exceeds the Loan SettlementAmount. As security for the performance by Thistle of its, and certain of itssubsidiaries', obligations under the SSCA, including in respect of thewarranties provided by it, Thistle has entered into a cession agreement datedOctober 29, 2007 under which it has ceded and assigned to Pamodzi, by way of asecurity cession, all of Thistle's rights and interests under the Loan andSubscription Agreement. Similarly, as security for the performance by Clidet ofits obligations under the Loan and Subscription Agreement and the othertransaction agreements (as applicable), Clidet has entered into a pledgeagreement dated October 29, 2007 under which it has ceded and pledged toThistle, by way of a security pledge, all of its rights, title and interest inand to the Underlying Pamodzi Gold Shares. For further information, contact: Anton Kakavelakis, Chief Financial Officer + 27 57 391 9026 or email toinfo@disselgroup.com Gerry Beaney or Troy MacDonald, Grant Thornton Corporate Finance at +44 (0) 207 383 5100 Forward Looking Information: This press release may contain or refer toforward-looking information based on current expectations. Forward-lookingstatements are subject to significant risks and uncertainties, and other factorsthat could cause actual results to differ materially from expected results.These forward-looking statements are made as of the date hereof and the Companyassumes no responsibility to update or revise them to reflect new events orcircumstances. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Apr 202410:00 amRNSIssue of Contingent Consideration Shares & TVR
2nd Apr 20247:00 amRNSFinal Results
28th Mar 20245:30 pmRNSFinal Results
17th Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDISPOSAL UPDATE - PATHFINDR
20th Dec 20237:34 amRNSTrading Statement
24th Nov 202312:46 pmRNSBoard Change
7th Nov 20232:47 pmRNSNotification of Major Holdings
31st Oct 20235:07 pmRNSHolding(s) in Company
31st Oct 20239:29 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSTRADING UPDATE AND REVISED OUTLOOK FOR 2023
19th Oct 20236:25 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2023
25th Sep 202310:27 amRNSNEW CONTRACT WIN
20th Sep 20239:44 amRNSInvestor Presentation
27th Jul 20237:01 amRNSTrading Update
27th Jul 20237:00 amRNSChange of Adviser
20th Jun 20232:44 pmRNSResult of AGM
20th Jun 20237:00 amRNSDirector Dealing
3rd Apr 20237:00 amRNSDividend Declaration
28th Mar 20237:00 amRNSFinal Results
24th Mar 20237:00 amRNSInvestor Presentation
16th Mar 202310:16 amRNSLaunch Of New Integrated Growth Media Agency
14th Feb 20237:00 amRNSACQUISITION OF MEZZO LABS
12th Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSACQUISITION OF INFLUENCE SPORTS & MEDIA
31st Oct 20224:39 pmRNSHolding(s) in Company
27th Sep 20227:01 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2022
27th Sep 20227:00 amRNSCHANGES TO THE BOARD
26th Aug 202210:27 amRNSHolding(s) in Company
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing
29th Jun 202211:54 amRNSEBT Share Dealing
21st Jun 20222:35 pmRNSResult of AGM
17th Jun 20227:00 amRNSEBT Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.